Skip to main content
FZ

Fzata, Inc.

Halethorpe, United States
Last funding
Undisclosed
GrantSep 2024

Fzata's novel platform modality for oral biologics is Bioengineered Probiotic Yeast Medicines (BioPYM) with over 10 GI drug candidates.

Backed byNational Institute of Neurological Disorders and Stroke

About Fzata, Inc.

Who are Fzata, Inc.'s investors?

Fzata, Inc.'s investors include National Institute of Neurological Disorders and Stroke.

Where is Fzata, Inc. headquartered?

Fzata, Inc. is headquartered in Halethorpe, United States.

What does Fzata, Inc. do?

Fzata's novel platform modality for oral biologics is Bioengineered Probiotic Yeast Medicines (BioPYM) with over 10 GI drug candidates.

What stage is Fzata, Inc. at?

Fzata, Inc. is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Fzata, Inc. — Funding & Investors." VCBacked, September 24, 2024, https://www.vcbacked.co/company/fzata-inc. Accessed November 14, 2026.
APA
VCBacked. (2024). Fzata, Inc. — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/fzata-inc
Wikipedia (cite web)
{{cite web |title=Fzata, Inc. — Funding & Investors |url=https://www.vcbacked.co/company/fzata-inc |website=VCBacked |access-date=November 14, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Fzata, Inc.? Request a listing update

Founder contacts
m***@fzata.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →